Cidara Therapeutics, Inc. — Director's Dealing 2021

Mar 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cidara Therapeutics, Inc. (CDTX)
CIK: 0001610618
Period of Report: 2021-03-17

Reporting Person: Stein Jeffrey (Director, President & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-17	Employee Stock Option (right to buy)	$2.55	A	525000	Acquired	2031-03-16	Common Stock (525000.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	351878	Direct
Common Stock	231602	Indirect
Common Stock	42009	Indirect

Footnotes

F1: Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 20, 2020.

F2: 26,300 shares transferred from trust to son.

F3: Includes 26,300 shares transferred from trust.

F4: The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 17, 2021.